Pimagedine is a prototype therapeutic agent for the prevention of formation of advanced glycation endproducts. Pimagedine reacts rapidly with alpha,beta-dicarbonyl compounds such as methylglyoxal, glyoxal, and 3-deoxyglucosone to prevent the formation of advanced glycation endproducts (AGEs).
Molecular Weight:
74.09
CAS Number:
[79-17-4]
Formula:
CH6N4
Target:
Apoptosis|||Others|||NO Synthase
T34066
* VAT and and shipping costs not included. Errors and price changes excepted